Literature DB >> 9359841

Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation.

S Allen1, N J Bulleid.   

Abstract

The roles of the endoplasmic-reticulum lectins calnexin and calreticulin in the folding of tissue-type plasminogen activator (tPA) have been investigated using an in vitro translation system that reconstitutes these processes as they would occur in the intact cell. Using co-immunoprecipitation of newly synthesized tPA with antibodies to calnexin and calreticulin, it was demonstrated that the interaction of tPA with both lectins was dependent upon tPA glycosylation and glucosidase trimming. When tPA was synthesized in the presence of semi-permeabilized cells under conditions preventing complex formation with calnexin and calreticulin, the translation product had a specific plasminogenolytic activity identical with that when synthesized under conditions permitting interactions with both lectins. Furthermore, complexes of tPA bound to calnexin and calreticulin were shown to be enzymically active. These results demonstrate that calnexin and calreticulin can form a stable interaction with correctly folded tPA; however, such interactions are not required for the synthesis of enzymically active tPA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359841      PMCID: PMC1218894          DOI: 10.1042/bj3280113

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Reduction of endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells.

Authors:  A J Dorner; M G Krane; R J Kaufman
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

3.  N-linked oligosaccharides are necessary and sufficient for association of glycosylated forms of bovine RNase with calnexin and calreticulin.

Authors:  A R Rodan; J F Simons; E S Trombetta; A Helenius
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins.

Authors:  J D Oliver; F J van der Wal; N J Bulleid; S High
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

5.  Esterification of the carboxyl groups in fibrinogen by the application of a highly specific methylating agent.

Authors:  A J Osbahr
Journal:  Thromb Haemost       Date:  1982-10-29       Impact factor: 5.249

6.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

Authors:  D C Rijken; D Collen
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

7.  Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.

Authors:  M J Gething; B Adler; J A Boose; R D Gerard; E L Madison; D McGookey; R S Meidell; L M Roman; J Sambrook
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

8.  Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum.

Authors:  U Tatu; A Helenius
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

9.  Inhibition of N-linked oligosaccharide trimming does not interfere with surface expression of certain integral membrane proteins.

Authors:  B Burke; K Matlin; E Bause; G Legler; N Peyrieras; H Ploegh
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins.

Authors:  A J Dorner; D G Bole; R J Kaufman
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  4 in total

1.  ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin.

Authors:  J D Oliver; H L Roderick; D H Llewellyn; S High
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

3.  Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.

Authors:  Harri Lempiäinen; Ingrid Brænne; Tom Michoel; Vinicius Tragante; Baiba Vilne; Tom R Webb; Theodosios Kyriakou; Johannes Eichner; Lingyao Zeng; Christina Willenborg; Oscar Franzen; Arno Ruusalepp; Anuj Goel; Sander W van der Laan; Claudia Biegert; Stephen Hamby; Husain A Talukdar; Hassan Foroughi Asl; Gerard Pasterkamp; Hugh Watkins; Nilesh J Samani; Timo Wittenberger; Jeanette Erdmann; Heribert Schunkert; Folkert W Asselbergs; Johan L M Björkegren
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

4.  Substrate specificity of the oxidoreductase ERp57 is determined primarily by its interaction with calnexin and calreticulin.

Authors:  Catherine E Jessop; Timothy J Tavender; Rachel H Watkins; Joseph E Chambers; Neil J Bulleid
Journal:  J Biol Chem       Date:  2008-12-03       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.